SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-026421
Filing Date
2024-03-05
Accepted
2024-03-05 18:00:07
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3278
  Complete submission text file 0000950170-24-026421.txt   4850
Mailing Address C/O ANTIGENICS INC. 162 FIFTH AVENUE, SUITE 900 NEW YORK NY 10010
Business Address
Corvese Brian (Reporting) CIK: 0001393207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40908 | Film No.: 24722900

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Issuer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)